Abstract
We have shown previously that the neuronal nitric oxide synthase (nNOS) is involved in the rewarding effect of cocaine as determined by the conditioned place preference (CPP) paradigm, in the present study we investigated the effect of the nNOS inhibitor 7-nitroindazole (7-NI) on nicotine-induced CPP and LiCl-induced conditioned place aversion (CPA) in Swiss Webstr mice. Mice treated with nicotine (0.5 mg/kg) or saline every other day for 8 days (four drug and four salien sessions) developed CPP that was completely blocked by pretreatment with 7-NI (25 mg/kg). Mice treated with LiCl (150 mg/kg) developed marked aversion to the LiCl-paired compartment LiCl-induced CPA was not affected by the pretreatment with 7-NI. These findings suggest that nitric oxide (NO) plays a role in the acquisition of reward but not of aversion and that the blockade of nicotine-induced CPP is probably not due to impairment of learning and memory. (C) 2000 Lippincott Williams and Wilkins.
| Original language | English |
|---|---|
| Pages (from-to) | 947-949 |
| Number of pages | 3 |
| Journal | NeuroReport |
| Volume | 11 |
| Issue number | 5 |
| State | Published - Apr 7 2000 |
Fingerprint
Keywords
- 7- Nitroindazole (7-NI)
- Aversion
- Lithium chloride (LiCl)
- Nicotine
- Nitric oxide (NO)
- Reward
ASJC Scopus subject areas
- Neuroscience(all)
Cite this
7-Nitroindazole blocks nicotine-induced conditioned place prefrence but not LiCl-induced conditioned place aversion. / Martin, Julio L.; Itzhak, Yossef.
In: NeuroReport, Vol. 11, No. 5, 07.04.2000, p. 947-949.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - 7-Nitroindazole blocks nicotine-induced conditioned place prefrence but not LiCl-induced conditioned place aversion
AU - Martin, Julio L.
AU - Itzhak, Yossef
PY - 2000/4/7
Y1 - 2000/4/7
N2 - We have shown previously that the neuronal nitric oxide synthase (nNOS) is involved in the rewarding effect of cocaine as determined by the conditioned place preference (CPP) paradigm, in the present study we investigated the effect of the nNOS inhibitor 7-nitroindazole (7-NI) on nicotine-induced CPP and LiCl-induced conditioned place aversion (CPA) in Swiss Webstr mice. Mice treated with nicotine (0.5 mg/kg) or saline every other day for 8 days (four drug and four salien sessions) developed CPP that was completely blocked by pretreatment with 7-NI (25 mg/kg). Mice treated with LiCl (150 mg/kg) developed marked aversion to the LiCl-paired compartment LiCl-induced CPA was not affected by the pretreatment with 7-NI. These findings suggest that nitric oxide (NO) plays a role in the acquisition of reward but not of aversion and that the blockade of nicotine-induced CPP is probably not due to impairment of learning and memory. (C) 2000 Lippincott Williams and Wilkins.
AB - We have shown previously that the neuronal nitric oxide synthase (nNOS) is involved in the rewarding effect of cocaine as determined by the conditioned place preference (CPP) paradigm, in the present study we investigated the effect of the nNOS inhibitor 7-nitroindazole (7-NI) on nicotine-induced CPP and LiCl-induced conditioned place aversion (CPA) in Swiss Webstr mice. Mice treated with nicotine (0.5 mg/kg) or saline every other day for 8 days (four drug and four salien sessions) developed CPP that was completely blocked by pretreatment with 7-NI (25 mg/kg). Mice treated with LiCl (150 mg/kg) developed marked aversion to the LiCl-paired compartment LiCl-induced CPA was not affected by the pretreatment with 7-NI. These findings suggest that nitric oxide (NO) plays a role in the acquisition of reward but not of aversion and that the blockade of nicotine-induced CPP is probably not due to impairment of learning and memory. (C) 2000 Lippincott Williams and Wilkins.
KW - 7- Nitroindazole (7-NI)
KW - Aversion
KW - Lithium chloride (LiCl)
KW - Nicotine
KW - Nitric oxide (NO)
KW - Reward
UR - http://www.scopus.com/inward/record.url?scp=0034616221&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0034616221&partnerID=8YFLogxK
M3 - Article
VL - 11
SP - 947
EP - 949
JO - NeuroReport
JF - NeuroReport
SN - 0959-4965
IS - 5
ER -